dtandukar
Newbie
Offline
Gender:
Posts: 18
|
|
« Reply #2 on: July 01, 2010, 06:03:00 PM » |
|
I went through a paper: Efficacy of Intravenous Methoxy Polyethylene Glycol-Epoetin Beta Administered Every 2 Weeks Compared With Epoetin Administered 3 Times Weekly in Patients Treated by Hemodialysis or Peritoneal Dialysis: A Randomized Trial
Marian Klinger, MD, PhD,1 Manual Arias, PhD,2 Vassilis Vargemezis, MD,3 Anatole Besarab, MD,4 Wladyslaw Sulowicz, MD, PhD,5 Trevor Gerntholtz, FCP (SA),6 Kazimierz Ciechanowski, MD, PhD,7 Frank C. Dougherty, MD,8 and Ulrich Beyer, PhD,8 on behalf of the AMICUS Study Investigators
this paper states that: "In summary, results of AMICUS showed that C.E.R.A. once every 2 weeks in patients with CKD on dialysis provided a high rate of response in conjunction with a smooth and steady increase in Hb levels while correcting anemia in accordance with current clinical guidelines. Our results show that C.E.R.A. once every 2 weeks is as effective and well tolerated as more frequent (3 times weekly) epoetin with predictable and controlled correction of anemia. These features have the potential to provide an advance in the management of anemia by minimizing renal unit workload during the correction of anemia."
I want to hear from users. Before dialysis my father was in mircera - in dialysis he was switched to eprex as dialysis technicians are comfortable with eprex and again we switched him to mircera after reading this article. Hope this is a +ve move.
Best regards, Deependra
|